4-(4-Chloro-1-methyl-1H-pyrazol-5-yl)-N-((3S,4S)-4-(3-fluorophenyl)piperidin-3-yl)thiophene-2-carboxamide hydrochloride

ID: ALA4451854

PubChem CID: 155521934

Max Phase: Preclinical

Molecular Formula: C20H21Cl2FN4OS

Molecular Weight: 418.93

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cl.Cn1ncc(Cl)c1-c1csc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)c1

Standard InChI:  InChI=1S/C20H20ClFN4OS.ClH/c1-26-19(16(21)9-24-26)13-8-18(28-11-13)20(27)25-17-10-23-6-5-15(17)12-3-2-4-14(22)7-12;/h2-4,7-9,11,15,17,23H,5-6,10H2,1H3,(H,25,27);1H/t15-,17+;/m0./s1

Standard InChI Key:  ZRBKTKQJJFAWIF-KPVRICSOSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   10.0085  -15.5349    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.6684  -14.1935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6684  -15.0107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3737  -15.4152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0790  -15.0107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0790  -14.1935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3737  -13.7808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3741  -12.9645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0834  -12.5565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0838  -11.7400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3755  -11.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6655  -11.7436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6686  -12.5587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9595  -13.7870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2530  -14.1977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5441  -13.7912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2554  -15.0149    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4541  -12.9803    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.6543  -12.8128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2478  -13.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7964  -14.1273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4297  -13.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9460  -12.8612    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1677  -13.1131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1668  -13.9312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9445  -14.1847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1972  -12.0836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1956  -14.9624    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.7917  -11.3318    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  7  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7  8  1  6
  2 14  1  1
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 16  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 22  2  0
 23 27  1  0
 26 28  1  0
 10 29  1  0
M  END

Associated Targets(Human)

AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HuT78 (515 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JVM-2 (152 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 418.93Molecular Weight (Monoisotopic): 418.1030AlogP: 3.82#Rotatable Bonds: 4
Polar Surface Area: 58.95Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.19CX LogP: 3.30CX LogD: 1.52
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.68Np Likeness Score: -1.37

References

1. Zhan W, Che J, Xu L, Wu Y, Hu X, Zhou Y, Cheng G, Hu Y, Dong X, Li J..  (2019)  Discovery of pyrazole-thiophene derivatives as highly Potent, orally active Akt inhibitors.,  180  [PMID:31301565] [10.1016/j.ejmech.2019.07.017]

Source